THANK YOU FOR SUBSCRIBING
Manufacturing Technology Insights | Tuesday, August 17, 2021
David Liebl joins the leadership position at Intricon to drive growth and significant value
FREMONT, CA: Intricon announces that David Liebl has joined the company as Vice President of R&D. Intricon Corporation is an international company engaged in designing, developing, engineering, and manufacturing miniature interventional, implantable, and body-worn medical devices. Intricon addresses each engagement with an all-in commitment, working with customers at every step, from the earliest idea stages to ongoing production, to enhance program performance and deliver results.
Stay ahead of the industry with exclusive feature stories on the top companies, expert insights and the latest news delivered straight to your inbox. Subscribe today.
Mr. Liebl has more than 25 years of engineering and product development experience at multiple high technology and medical technology companies. Recently, he has served as the President of Biomericsat NLEs West Operations. Before his role at Biomerics, he held several positions at Heraeus Medical Components/NeoMetrics, Inc., including EVP, Product and Business Development, President and CTO, and VP, Development spanning from 2005 to 2019. His career also includes Director and Vice President level positions at Pearson, Datacard Group, and MedAmicus, Inc.
“We are very excited to welcome Dave to the Intricon team. His rich and diverse background combining technology, business and product development, regulatory affairs and M&A made him an ideal fit for this new key leadership position,” said Scott Longval, President and Chief Executive Officer atIntricon. “Over the past 18 months, one of our priorities has been to expand and strengthen our talent to enhance our position as a Joint Development Manufacturer and the addition of Dave further highlights our progress.”
“I am thrilled by the opportunity to join Intricon,” said Mr. Liebl. “I am confident that my broad background will enable me to drive significant value as we continue to explore opportunities in high growth markets and enhancements to our technology.”
More in News